213 related articles for article (PubMed ID: 22471294)
1. Lysosomal delivery of a lipophilic gemcitabine prodrug using novel acid-sensitive micelles improved its antitumor activity.
Zhu S; Lansakara-P DS; Li X; Cui Z
Bioconjug Chem; 2012 May; 23(5):966-80. PubMed ID: 22471294
[TBL] [Abstract][Full Text] [Related]
2. The effect of the acid-sensitivity of 4-(N)-stearoyl gemcitabine-loaded micelles on drug resistance caused by RRM1 overexpression.
Zhu S; Wonganan P; Lansakara-P DS; O'Mary HL; Li Y; Cui Z
Biomaterials; 2013 Mar; 34(9):2327-39. PubMed ID: 23261218
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of gemcitabine and cisplatin via Poly (L-glutamic acid)-g-methoxy poly (ethylene glycol) micelle to improve the in vivo stability and antitumor effect.
Ding N; Zhao Z; Yin N; Xu Y; Yin T; Gou J; He H; Wang Y; Zhang Y; Tang X
Pharm Res; 2021 Dec; 38(12):2091-2108. PubMed ID: 34893950
[TBL] [Abstract][Full Text] [Related]
4. Enhanced tumor delivery of gemcitabine via PEG-DSPE/TPGS mixed micelles.
Wang Y; Fan W; Dai X; Katragadda U; Mckinley D; Teng Q; Tan C
Mol Pharm; 2014 Apr; 11(4):1140-50. PubMed ID: 24579673
[TBL] [Abstract][Full Text] [Related]
5. Preparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: a comparison with its self-assembled nanoparticles.
Daman Z; Ostad S; Amini M; Gilani K
Int J Pharm; 2014 Jul; 468(1-2):142-51. PubMed ID: 24731731
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of gemcitabine prodrug along with anti NF-κB siRNA by tri-layer micelles can increase cytotoxicity, uptake and accumulation of the system in the cancers.
Norouzi P; Amini M; Dinarvand R; Arefian E; Seyedjafari E; Atyabi F
Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111161. PubMed ID: 32806226
[TBL] [Abstract][Full Text] [Related]
7. Stereocomplex Prodrugs of Oligo(lactic acid)
Tam YT; Huang C; Poellmann M; Kwon GS
ACS Nano; 2018 Jul; 12(7):7406-7414. PubMed ID: 29957934
[TBL] [Abstract][Full Text] [Related]
8. Just getting into cells is not enough: mechanisms underlying 4-(N)-stearoyl gemcitabine solid lipid nanoparticle's ability to overcome gemcitabine resistance caused by RRM1 overexpression.
Wonganan P; Lansakara-P DS; Zhu S; Holzer M; Sandoval MA; Warthaka M; Cui Z
J Control Release; 2013 Jul; 169(1-2):17-27. PubMed ID: 23570983
[TBL] [Abstract][Full Text] [Related]
9. A nanoparticle depot formulation of 4-(N)-stearoyl gemcitabine shows a strong anti-tumour activity.
Zhu S; Li X; Lansakara-P DS; Kumar A; Cui Z
J Pharm Pharmacol; 2013 Feb; 65(2):236-42. PubMed ID: 23278691
[TBL] [Abstract][Full Text] [Related]
10. Polymeric Micelles of PEG-PLA Copolymer as a Carrier for Salinomycin Against Gemcitabine-Resistant Pancreatic Cancer.
Daman Z; Montazeri H; Azizi M; Rezaie F; Ostad SN; Amini M; Gilani K
Pharm Res; 2015 Nov; 32(11):3756-67. PubMed ID: 26228105
[TBL] [Abstract][Full Text] [Related]
11. Theranostic reduction-sensitive gemcitabine prodrug micelles for near-infrared imaging and pancreatic cancer therapy.
Han H; Wang H; Chen Y; Li Z; Wang Y; Jin Q; Ji J
Nanoscale; 2016 Jan; 8(1):283-91. PubMed ID: 26608864
[TBL] [Abstract][Full Text] [Related]
12. One-step preparation of reduction-responsive cross-linked gemcitabine prodrug micelles for intracellular drug delivery.
Chen X; Teng W; Jin Q; Ji J
Colloids Surf B Biointerfaces; 2019 Sep; 181():94-101. PubMed ID: 31125923
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
[TBL] [Abstract][Full Text] [Related]
14. 4-Carboxyphenylboronic acid-decorated, redox-sensitive rod-shaped nano-micelles fabricated through co-assembling strategy for active targeting and synergistic co-delivery of camptothecin and gemcitabine.
Xu Y; Huang Y; Lu W; Liu S; Xiao Y; Yu J
Eur J Pharm Biopharm; 2019 Nov; 144():193-206. PubMed ID: 31560954
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles.
Sloat BR; Sandoval MA; Li D; Chung WG; Lansakara-P DS; Proteau PJ; Kiguchi K; DiGiovanni J; Cui Z
Int J Pharm; 2011 May; 409(1-2):278-88. PubMed ID: 21371545
[TBL] [Abstract][Full Text] [Related]
16. Oligo(Lactic Acid)
Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
[TBL] [Abstract][Full Text] [Related]
17. Effect of surface mannosylation on the cytotoxicity and cellular uptake of stearoyl gemcitabine-incorporated, acid-sensitive micelles.
Alzhrani RF; Xu H; Valdes SA; Naguib YW; Cui Z
Colloid Interface Sci Commun; 2021 Jul; 43():. PubMed ID: 34307073
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs.
Immordino ML; Brusa P; Rocco F; Arpicco S; Ceruti M; Cattel L
J Control Release; 2004 Dec; 100(3):331-46. PubMed ID: 15567500
[TBL] [Abstract][Full Text] [Related]
19. Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery.
Kanamala M; Palmer BD; Jamieson SM; Wilson WR; Wu Z
Nanomedicine (Lond); 2019 Aug; 14(15):1971-1989. PubMed ID: 31355712
[No Abstract] [Full Text] [Related]
20. Co-delivery of 2-Deoxyglucose and a glutamine metabolism inhibitor V9302 via a prodrug micellar formulation for synergistic targeting of metabolism in cancer.
Luo Z; Xu J; Sun J; Huang H; Zhang Z; Ma W; Wan Z; Liu Y; Pardeshi A; Li S
Acta Biomater; 2020 Mar; 105():239-252. PubMed ID: 31958597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
